» Articles » PMID: 31128614

Interrelational Changes in the Epidemiology and Clinical Features of Nontuberculous Mycobacterial Pulmonary Disease and Tuberculosis in a Referral Hospital in Japan

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2019 May 27
PMID 31128614
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: The incidence of nontuberculous mycobacterial pulmonary disease (NTM-PD) is increasing, while that of tuberculosis (TB) is decreasing in many industrialized countries, including Japan. However, the long-term evaluation of clinico-epidemiological features of NTM-PD in relation to TB are limited. We aimed to clarify the long-term changes in the epidemiology and clinical features of NTM-PD in relation to those of TB at a nationally-designated TB center in Japan.

Methods: We reviewed all mycobacterial examination records at Fukujuji Hospital between 2006 and 2016. Cases of NTM-PD were defined according to the 2007 American Thoracic Society/Infectious Disease Society of America microbiologic criteria. The current characteristics of Mycobacterium avium complex pulmonary disease (MAC-PD) were compared with those in the 1980s and circa 2000.

Results: We identified a total of 3,546 pulmonary TB cases and 2,155 NTM-PD cases. While the annual number of incident pulmonary TB cases remained stable over the study period (P = 0.59), that of NTM-PD cases increased significantly from 165 to 278 (P < 0.01). The mean age of pulmonary TB cases increased from 59.7 ± 16.3 to 66.2 ± 21.7 years, whereas that of NTM-PD cases remained unchanged. Regarding the age distribution, the greatest increases were observed in patients over 75 years for TB and in patients 50-74 years for NTM. The most common causative organism for NTM was Mycobacterium avium complex (87.3%), M. abscessus complex (5.5%) and M. kansasii (3.9%). Among patients with MAC-PD, the proportion of the nodular bronchiectatic (NB) form increased significantly from 60.0% to 84.4% between circa 2000 and 2016 (P < 0.01). Significant increases in the NB form were observed in both males (33.3%-70.7%, P < 0.01) and females (71.3%-89.2%, P < 0.01).

Conclusions: The annual number of incident NTM-PD cases increased markedly. In contrast to patients with TB, the mean age of new NTM-PD patients did not increase in the last 10 years. Among MAC-PD patients, the proportions accounted for by the NB form increased significantly in both sexes.

Citing Articles

Laboratory-based surveillance of nontuberculous mycobacterial pulmonary disease in Japan.

Hamaguchi Y, Morimoto K, Mitarai S ERJ Open Res. 2025; 11(1).

PMID: 39963166 PMC: 11831631. DOI: 10.1183/23120541.00337-2024.


Non-tuberculous enhance the tryptophan-kynurenine pathway to induce immunosuppression and facilitate pulmonary colonization.

Li L, Shao J, Tong C, Gao W, Pan P, Qi C Front Cell Infect Microbiol. 2024; 14:1455605.

PMID: 39497924 PMC: 11532197. DOI: 10.3389/fcimb.2024.1455605.


Nontuberculous Mycobacteria Isolates in Respiratory Samples and Mycobacterial Pulmonary Disease in an Area of Northern Spain.

Ugedo J, Tabernero E, Altube L, Leal M, Garcia J Open Respir Arch. 2024; 6(4):100353.

PMID: 39318829 PMC: 11421231. DOI: 10.1016/j.opresp.2024.100353.


A retrospective study differentiating nontuberculous mycobacterial pulmonary disease from pulmonary tuberculosis on computed tomography using radiomics and machine learning algorithms.

Zhou L, Wang Y, Zhu W, Zhao Y, Yu Y, Hu Q Ann Med. 2024; 56(1):2401613.

PMID: 39283049 PMC: 11407416. DOI: 10.1080/07853890.2024.2401613.


Diagnostic value of nanopore sequencing technology in nontuberculous mycobacterial pulmonary disease.

Lin W, Tang F, Liu S Am J Transl Res. 2024; 16(8):4208-4215.

PMID: 39262756 PMC: 11384362. DOI: 10.62347/HHRH8076.